Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial-Reference-Cited by-同舟云学术

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial

Published:2013-01 Issue:9862 Volume:381 Page:214-222
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Palmu Arto A,Jokinen Jukka,Borys Dorota,Nieminen Heta,Ruokokoski Esa,Siira Lotta,Puumalainen Taneli,Lommel Patricia,Hezareh Marjan,Moreira Marta,Schuerman Lode,Kilpi Terhi M

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children;Black;Pediatr Infect Dis J,2000

2. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine;Whitney;N Engl J Med,2003

3. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway;Vestrheim;Vaccine,2008

4. Herd immunity and serotype replacement four years after pneumococcal conjugate vaccination in England and Wales: an observational cohort study;Miller;Lancet Infect Dis,2011

5. Pneumococcal disease in South Australia: vaccine success but no time for complacency;Johnson;Vaccine,2012

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why and when should we cluster randomize?;Journal of Epidemiology and Population Health;2024-02

2. Bacterial capsules;Molecular Medical Microbiology;2024

3. Simplified consent in cluster randomised trials: the new EU Clinical Trials Regulation does not provide sufficient guidance;BMJ;2023-09-13

4. Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998–2022;Frontiers in Public Health;2023-08-31

5. Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults;npj Vaccines;2023-05-25